Skip Navigation

American Journal of Epidemiology 2004 160(7):619-627; doi:10.1093/aje/kwh272
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Brinton, L. A.
Right arrow Articles by Hoover, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brinton, L. A.
Right arrow Articles by Hoover, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2004 by the Johns Hopkins Bloomberg School of Public Health

ORIGINAL CONTRIBUTIONS

Risk of Connective Tissue Disorders among Breast Implant Patients

Louise A. Brinton1 , Lenore M. Buckley2, Olga Dvorkina3, Jay H. Lubin1, Theodore Colton4, Mary Cay Murray5 and Robert Hoover1

1 Epidemiology and Biostatistics Program, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD.
2 School of Medicine, Virginia Commonwealth University, Richmond, VA.
3 State University of New York Health Science Center at Brooklyn, Brooklyn, NY.
4 School of Public Health, Boston University, Boston, MA.
5 Abt Associates, Inc., Chicago, IL.

In a US retrospective cohort study (1960–1996), 351 (4.8%) of 7,234 patients with breast implants and 62 (2.9%) of 2,138 patients who had undergone other types of plastic surgery reported subsequent rheumatoid arthritis (RA), scleroderma, systemic lupus erythematosus, or Sjögren’s syndrome (relative risk = 2.0, 95% confidence interval (CI): 1.5, 2.8). Risks of RA, scleroderma, and Sjögren’s syndrome were elevated both before and after 1992, when the Food and Drug Administration changed the status of breast implants to investigational. When records for these diseases were retrieved (35–40% retrieval rate) and blindly reviewed, two expert rheumatologists assessed only a minority of the cases as being "likely" (e.g., regarding RA, 16.5% for implant patients and 23.5% for comparison patients). Recalculation of incidence rates using "likely" diagnoses found relative risks of 2.5 (95% CI: 0.8, 7.8) for RA, scleroderma, and Sjögren’s syndrome combined and 1.9 (95% CI: 0.6, 6.2) for RA only. When the proportions deemed "likely" were applied to all self-reports, the estimated relative risks were 2.0 (95% CI: 0.7, 5.4) for the three disorders combined and 1.3 (95% CI: 0.5, 3.8) for RA. These results indicate that self-reports of connective tissue disorders are influenced by reporting and surveillance biases. Given the diagnostic complexities of these diseases, excess risks, if they exist, may be beyond detection even in a study of this size.

arthritis, rheumatoid; breast implants; connective tissue diseases; risk; scleroderma, systemic; Sjögren’s syndrome

Abbreviations: Abbreviations: CI, confidence interval; CTD(s), connective tissue disorder(s); RR, relative risk.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch SurgHome page
D. Zuckerman
Reconstructive Breast Implantation After Mastectomy
Arch Surg, July 1, 2006; 141(7): 714 - 715.
[Full Text] [PDF]


Home page
JWatch Women's HealthHome page
Breast Implants and Connective Tissue Disorders: No Apparent Link
Journal Watch Women's Health, December 8, 2004; 2004(1208): 2 - 2.
[Full Text]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.